Scientific publications Scientific publications

  • D. Medaglini, C.-A. Siegrist. Immunomonitoring of human responses to the rVSV-ZEBOV Ebola vaccineCurr Opin Virol. doi: 10.1016/j.coviro.2017.03.008  

            http://www.sciencedirect.com/science/article/pii/S1879625716301523

 

  • A. Huttner, C. Combescure, S. Grillet, M. C. Haks, E. Quinten, C. Modoux, S. T. Agnandji,
    J. Brosnahan, J.-A. Dayer, A. M. Harandi, L. Kaiser, D. Medaglini, T. Monath, VEBCON and
    VSV-EBOVAC Consortia, P. Roux-Lombard, P. G. Kremsner, T. H. M. Ottenhoff, C.-A. Siegrist. A
    dose-dependent plasma signature of the safety and immunogenicity of the rVSV-Ebola
    vaccine in Europe and Africa
    . Sci. Transl. Med. 9, eaaj1701 (2017)   

            http://stm.sciencemag.org/content/9/385/eaaj1701

 

  • D. Medaglini, A. M. Harandi, T. H. M. Ottenhof, C.A. Siegrist, VSV-EBOVAC Consortium. Ebola vaccine R&D: Filling the knowledge gapsSci Transl Med. 2015 ;7(317):317ps24. doi: 10.1126/scitranslmed.aad3106

            http://stm.sciencemag.org/content/scitransmed/7/317/317ps24

 

  • A. Huttner, J.A. Dayer, S. Yerly, C. Combescure, F. Auderset, J. Desmeules, M. Eickmann, A. Finckh, A.R. Goncalves, J.W. Hooper, G. Kaya, V. Krahling, S. kwilas, B. Lemaitre, A. Matthey, P. Silvera, S. Becker, P. Fast, V. Moorthy, M.P. Kieny, L. Kaiser, C.A. Siegrist, and VSV-Ebola Consortium. The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trialLancet Infect Dis. DOI: 10.1016/S1473-3099(15)00154-1 (2015)

          http://www.sciencedirect.com/science/article/pii/S1473309915001541

 

  • S.T. Agnandji, A. Huttner, M.E. Zinser, P. Njuguna, C. Dahlke, J.F. Fernandes, S. Yerly, J.A. Dayer, V. Kraehling, R. Kasonta, A.A. Adegnika, M. Altfeld, F. Auderset, E.B. Bache, N. Biedenkopf, S. Borregaard, J.S. Brosnahan, R. Burrow, C. Combescure, J. Desmeules, M. Eickmann, S.K. Fehling, A. Finckh, A.R. Goncalves, M.P. Grobusch, J. Hooper, A. Jambrecina, A.L. Kabwende, G. Kaya, D. Kimani, B. Lell, B. Lemaitre, A.W. Lohse, M. Massinga-Loembe, A. Matthey, B. Mordmuller, A. Nolting, C. Ogwang, M. Ramharter, J. Schmidt-Chanasit, S. Schmiedel, P. Silvera, F.R. Stahl, H.M. Staines, T. Strecker, H.C. Stubbe, B. Tsofa, S. Zaki, P. Fast, V. Moorthy, L. Kaiser, S. Krishna, S. Becker, M.P. Kieny, P. Bejon, P.G. Kremsner, M.M. Addo, and C.A. Siegrist. Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe - Preliminary Report. N Engl J Med. DOI: 10.1056/NEJMoa1502924 (2015).

          http://www.nejm.org/doi/full/10.1056/NEJMoa1502924